AI-driven scientific discovery will become the primary method for new material and drug development.

AI-Driven Scientific Discovery Will Become Standard by 2044

By 2044, AI-driven scientific discovery methods will become the primary method for new material and drug development. This revolution, which began with Google DeepMind's GNoME system predicting 2.2 million new crystal structures in 2023, will change the fundamental paradigm of scientific research within 20 years.

The End of Traditional Methods

Traditional trial-and-error methods will become unable to compete with AI's high-throughput virtual screening and precise property prediction. Laboratories will be managed by autonomous AI systems.

Economic Impact

- **Drug development time:** Reduced from 10-15 years to 2-3 years. - **New material discovery:** Revolution in batteries, solar panels, and superconductors. - **Cost:** R&D costs will decrease by 70-80%.

This transformation will change the role of scientists: humans will form hypotheses, AI will test and discover.

Probability

%70

Verification Criteria

A peer-reviewed paper in Nature or Science announces that an AI-discovered material or drug has entered human clinical trials or commercial production.

Confidence Level

HighGoogle DeepMind's GNoME system predicted 2.2 million new crystal structures in 2023. AI-driven discovery speed doubles every 2 years; by 2044, it is expected to completely surpass traditional methods.

Sources

Google DeepMind GNoME: 2.2 Million New Crystal Structures Predicted AI in Materials Discovery Market to Reach $2.77 Billion by 2030

Loading…